This Toronto based research group used a combination of TGF-b1 and IL-15 to induce a CD103+/CD49a+ phenotype in peripheral blood derived NK cells. Co incubation with this NK cell line inhibited CD4 T cell proliferation and percentage of CD25+ T cells.
Cookie Consent
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Cookie Preferences
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Name
Description
Duration
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
-
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
-
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.